Pilot Study Intended to Provide Input for Future Designs Using the PET Alpha Ring Detector

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

51 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

A standard PET/CT scanner is comprised of two different machines: An X-ray computed tomography scanner (CT), which gives information about your anatomy, and a Positron Emission Tomography scanner (PET) that provides information about how the body functions. Both of these work together to make the final images for doctors to review. As part of this research study the investigators would like to test a new scanner technology by evaluating the quality of the images obtained using this new PET system.

The scanner the investigators would use is able to do both types of examination, the standard PET/CT and the additional research PET. The new PET system adds a second scanner ring to the standard PET/CT. This allows the patient to stay on the same imaging table for both studies. Being in this study does not change how the standard PET/CT will be done.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Refinement and Assessment of New Magnetic Resonance Imaging (MRI) Technologies for Vascular, Abdominal, and Pelvic Exams

NCT00738712

Healthy

COMPLETED NA

Non-Invasive Imaging of Atherosclerosis

NCT01418313

Atherosclerosis

COMPLETED

High Image Matrix CT Reconstruction

NCT02610465

Healthy Subjects Pulmonary-Related Conditions Cardiac-Related Conditions

COMPLETED

Technical Development of Cardiovascular Magnetic Resonance Imaging

NCT00027170

Cardiomyopathy Congenital Heart Disease Cardiovascular Disease +2 more

COMPLETED

Development and Evaluation of Techniques for Computer Aided Detection and Diagnosis From Existing Radiologic Images

NCT04579237

Radiology Information Systems

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Focus of Study is Imaging Performance With the New Technology Compared With the Currently Available Technology.

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients receiving PET/CT

Patients already scheduled for a clinically necessary PET/CT scan.

Group Type EXPERIMENTAL

Additional PET Scan

Intervention Type DEVICE

Additional PET Scan with no additional radiopharmaceutical administration.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Additional PET Scan

Additional PET Scan with no additional radiopharmaceutical administration.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients are at least 18 years
* Patients are medically stable
* Patients scheduled for clinically necessary PET/CT examination

Exclusion Criteria

* Patients who are pregnant
* Patients who are unwilling/unable to sign the Informed Consent Form
* Patients who are cognitively impaired and unable to provide informed consent
* Patients who have experienced adverse events to PET/CT examinations

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No